Kfir Umansky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article REHOVOT and JERUSALEM , Israel, April 6, 2021 /PRNewswire/ -- MyBiotics Pharma Ltd. http://biomx.com/, a microbiome therapeutics company, and Hadasit Medical Research Services and Development Ltd., the technology transfer office of Hadassah Medical Center, announced today that they have entered into a research collaboration and licensing agreement for the identification of microbiome-based therapeutics that will enhance the response to and reduce adverse effects of anti-PD-1 and anti-PD-L1 in melanoma patients. The collaboration will combine Hadassah's knowhow and experti...

Shoshanna Solomon is The Times of Israel's Startups and Business reporter A 3D illustrative image of rod-shaped bacteria and cocci in the human microbiome (Dr_Microbe; iStock by Getty Images) MyBiotics Pharma Ltd. said Tuesday it will work with Hadasit Medical Research Services and Development Ltd., the technology transfer arm of Hadassah Medical Center, to identify microbiome-based therapies to improve the impact of cancer immunotherapies in melanoma patients. MyBiotics has developed technologies to culture, ferment and deliver highly stable and diverse bacterial communities that can target ...